#epigeneticsmarket

Epigenetics Market Size is forecast to reach $ 5,115.20 Million by 2030, at a CAGR of 17.50% during forecast period 2024-2030.

📊 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞

#Epigenetics is the study of changes in gene activity that

don't involve alterations to the genetic code itself. These changes can be

influenced by various factors such as environment, lifestyle, and experiences.

They can impact gene expression and, consequently, traits and health outcomes.Understanding epigenetics is crucial for unraveling complex interactions between nature and nurture in shaping an organism's development and susceptibility to diseases.

The epigenetics market is experiencing exponential growth fueled by advancements in technology. The latest methods, such as #CRISPR-based #epigenome editing, are revolutionizing research and applications. These breakthroughs enable precise manipulation of gene expression, offering unprecedented insights into diseases, aging, and personalized medicine. As demand surges for innovative solutions, the epigenetics market is poised for substantial expansion and transformative impact.

The recognition of epigenetic modifications as viable targets for drug discovery is propelling market growth. Pharmaceutical firms are heavily investing in epigenetic research to develop groundbreaking therapies. For instance, in cancer treatment, drugs such as Azacitidine and Decitabine, which target #DNA methylation, have revolutionized therapy options,demonstrating the market's potential. Similarly, research into epigenetic therapies for neurological disorders and autoimmune diseases is accelerating,further driving market expansion.

The global Epigenetics Market is segmented based on deployment, component, solution, application, and geography. The segmentation in this research study has been finalized post in-depth secondary research and extensive primary research. In addition, the market is also segmented on the basis of products offered by the leading participants in the industry in order to understand widely used market specific terminologies. Thus, we have incorporated the segments of the research and have finalized the market segmentation.

The research report focuses on the current market trends, opportunities, future potential of the market, and competition in the Epigenetics in North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also provides market insights and analysis of the Epigenetics, highlighting the technological market trends, adoption rate, industry dynamics, and competitive analysis of major players in the industry.

The declining costs associated with different strategies and methods for sequencing supports to influence the scale and scope of almost all genomic research projects. The costs associated with DNA sequencing performed at the sequencing centers which is funded by the Institutes, has tracked by the National Human Genome Research Institute (NHGRI) for many years.

Global Epigenetics Market was valued at US$ XX billion in 2020 and is anticipated to reach US$ XX billion by 2027 displaying an elevated CAGR of XX% over the forecast period (2021-2027). Epigenetics is a stream of genetics that involves the study of how the cells control gene activity without altering the sequence of DNA i.e., these modifications bring out only phenotypic changes in an organism rather than genotypic change. Epigenetic changes are basically the modifications in DNA that regulate whether genes are turned on or off. These alterations are dynamic and are stable enough to pass from one generation to another.

The epigenetics market is growing exponentially on account of growth in mortality rates and incidences of cancer and other chronic diseases coupled with the heavy demand for medicines across the world. For instance, according to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 9.6 million deaths in 2018. this number has been increased and has reached around 10 million deaths globally in 2020. consequently, scientists across the world are carrying out high-level research on cancer therapeutics and diagnostics including research on epigenetics biomarkers as many recent studies suggest that epigenetic changes correlate with cancer development

Furthermore, the reduced sequencing cost is also anticipated to boost market growth. The cost of whole-genome sequencing has dropped promptly over the last decade with the emergence of next-generation sequencing. Additionally, with rapid technological advancement and rising investment in the research & development of pharmaceutical & biotechnology companies, the epigenetics market is witnessing an uptick all over the globe. For instance, The Pharmaceutical Research and Manufacturers of America (PhRMA) trade group represents the leading biopharmaceutical research companies in the United States. In 2019, the research and development (R&D) expenditure of its member companies reached USD 83 billion worldwide, up from USD 79.6 billion in 2018.

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/epigenetics-marketcurrent-forecast-market-2021-2027-644

Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Merck & co, Abcam PLC, Active Motif, and Diagenode are some of the prominent players operating in the global epigenetics market. Several M&A's along with partnerships have been undertaken by these players to develop new and advanced epigenetics products.

Insights Presented in the Report

"Amongst product, kits segment holds the major share"

Based on products & services, the market is fragmented into enzymes, instruments, kits, reagents, and others. The kits segment generated revenue of USD XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the growing adoption of epigenetics procedures and increase in the launch of new and advanced epigenetics kits by major industry players. For instance, in 2020, Bio-synergy, an award-winning supplements and sports nutrition company launched the world's first-ever combined DNA & Epigenetic testing kit that provides individuals with custom-made health, performance and lifestyle advice based on their specific genetic makeup. Further, this segment is also sub-segmented into ChIP-sequencing kits, RNA sequencing kits, Bisulfite conversion kits, Whole genome amplification kits, 5-hmC & 5-mC analysis kits, and others.

"Amongst application, oncology is anticipated to grow at the highest CAGR during the analyzed period"

Based on application, the market is fragmented into oncology, metabolic diseases, immunology, developmental biology, cardiovascular diseases, and others. The oncology segment generated revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the rising potential of epigenetics in the identification of biomarkers and growing demand for epigenetics in cancer research.

Amongst end-user, the pharmaceutical & biotechnology companies segment holds the major share"

Based on end-users, the market is fragmented into pharmaceutical & biotechnology, academic & research institutes, contract research organizations, and others. The pharmaceutical & biotechnology companies segment generated revenue of USD XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the increase in the number of pharmaceutical & biotechnology companies across the globe. For instance, according to India Brand Equity Foundation, the domestic pharmaceutical industry in India includes a network of 3,000 drug companies and nearly 10,500 manufacturing units.

"North America signifies one of the largest markets of epigenetics Market"

For a better understanding of the market dynamics of the epigenetics market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX million in 2020 owing to period owing to wide adoption of epigenetic solutions and growing awareness among researchers regarding its application in the early detection of cancer. At the same time, Asia-Pacific is anticipated to grow at the highest CAGR of XX% during the forecast period.

Reasons to buy this report:

? The study includes market sizing and forecasting analysis validated by authenticated key industry experts

? The report presents a quick review of overall industry performance at one glance

? The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

? Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

? The study comprehensively covers the market across different segments

? Deep dive regional level analysis of the industry

Customization Options:

The epigenetics market can further be customized as per the requirement or any other market segment.

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/epigenetics-marketcurrent-forecast-market-2021-2027-644

Table of content

1 MARKET INTRODUCTION 1.1 Market Definitions 1.2 Objective of the Study 1.3 Limitation 1.4 Stake Holders 1.5 Currency Used in Report 1.6 Scope of the Global Epigenetics Market Study 2 RESEARCH METHODOLOGY OR ASSUMPTION 2.1 Research Methodology for the Global Epigenetics Market 2.1.1 Main Objective of the Global Epigenetics Market 3 MARKET SYNOPSIS 4 EXECUTIVE SUMMARY 5 COVID-19 IMPACT 6 GLOBAL EPIGENETICS MARKET REVENUE 7 MARKET INSIGHTS BY PRODUCT 7.1 Enzymes 7.1.1 DNA-modifying enzymes 7.1.2 Protein-modifying enzymes 7.1.3 RNA-modifying enzymes 7.2 Instruments 7.2.1 Nex-generation sequencers 7.2.2 qPCRs 7.2.3 Mass spectrometers 7.2.4 Sonicators 7.2.5 Others 7.3 Kits 7.3.1 ChIP-sequencing kits 7.3.2 RNA sequencing kits 7.3.3 Bisulfite conversion kits 7.3.4 Whole genome amplification kits 7.3.5 5-hmC & %-mC analysis kits 7.3.6 Others 7.4 Reagents 7.4.1 Antibodies 7.4.2 Buffers 7.4.3 Histones 7.4.4 Magnetic beads 7.4.5 Primers 7.4.6 Others 7.5 Others 8 MARKET INSIGHTS BY APPLICATION 8.1 Oncology 8.2 Metabolic diseases 8.3 Immunology 8.4 Developmental biology 8.5 Cardiovascular diseases 8.6 Others 9 MARKET INSIGHTS BY END-USERS 9.1 Pharmaceutical & Biotechnology Companies 9.2 Academic & Research Institutes 9.3 Contract Research Organizations 9.4 Others 10 MARKET INSIGHTS BY REGION 10.1 NORTH AMERICA EPIGENETICS MARKET